BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18455514)

  • 1. High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells.
    Hattori Y; Nakano Y; Hattori S; Tomizawa A; Inukai K; Kasai K
    FEBS Lett; 2008 May; 582(12):1719-24. PubMed ID: 18455514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of AMP-activated protein kinase by kainic acid mediates brain-derived neurotrophic factor expression through a NF-kappaB dependent mechanism in C6 glioma cells.
    Yoon H; Oh YT; Lee JY; Choi JH; Lee JH; Baik HH; Kim SS; Choe W; Yoon KS; Ha J; Kang I
    Biochem Biophys Res Commun; 2008 Jul; 371(3):495-500. PubMed ID: 18445478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells.
    Cacicedo JM; Yagihashi N; Keaney JF; Ruderman NB; Ido Y
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1204-9. PubMed ID: 15504342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy.
    Wang C; Li L; Zhang ZG; Fan D; Zhu Y; Wu LL
    J Cell Physiol; 2010 Jan; 222(1):149-55. PubMed ID: 19780028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of adiponectin isoforms in human monocytic cells.
    Neumeier M; Weigert J; Schäffler A; Wehrwein G; Müller-Ladner U; Schölmerich J; Wrede C; Buechler C
    J Leukoc Biol; 2006 Apr; 79(4):803-8. PubMed ID: 16434692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARalpha activators upregulate eNOS activity and inhibit cytokine-induced NF-kappaB activation through AMP-activated protein kinase activation.
    Okayasu T; Tomizawa A; Suzuki K; Manaka K; Hattori Y
    Life Sci; 2008 Apr; 82(15-16):884-91. PubMed ID: 18346759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin induces NF-kappaB activation that leads to suppression of cytokine-induced NF-kappaB activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin.
    Tomizawa A; Hattori Y; Kasai K; Nakano Y
    Diab Vasc Dis Res; 2008 Jun; 5(2):123-7. PubMed ID: 18537100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes.
    Suzuki K; Uchida K; Nakanishi N; Hattori Y
    Am J Hypertens; 2008 Apr; 21(4):451-7. PubMed ID: 18369362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVEC.
    Murakami H; Murakami R; Kambe F; Cao X; Takahashi R; Asai T; Hirai T; Numaguchi Y; Okumura K; Seo H; Murohara T
    Biochem Biophys Res Commun; 2006 Mar; 341(4):973-8. PubMed ID: 16442496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.
    Huang NL; Chiang SH; Hsueh CH; Liang YJ; Chen YJ; Lai LP
    Int J Cardiol; 2009 May; 134(2):169-75. PubMed ID: 18597869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways.
    Tang CH; Lu ME
    Prostate; 2009 Dec; 69(16):1781-9. PubMed ID: 19676095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMP-activated kinase may suppress NADPH oxidase activation in vascular tissues.
    McCarty MF; Barroso-Aranda J; Contreras F
    Med Hypotheses; 2009 Apr; 72(4):468-70. PubMed ID: 19181455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective purification and characterization of adiponectin multimer species from human plasma.
    Hada Y; Yamauchi T; Waki H; Tsuchida A; Hara K; Yago H; Miyazaki O; Ebinuma H; Kadowaki T
    Biochem Biophys Res Commun; 2007 May; 356(2):487-93. PubMed ID: 17368570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndrome.
    McCarty MF
    Med Hypotheses; 2005; 64(6):1211-5. PubMed ID: 15823720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of AMP-activated protein kinase suppresses IL-2 expression through down-regulation of NF-AT and AP-1 activation in Jurkat T cells.
    Jhun BS; Lee JY; Oh YT; Lee JH; Choe W; Baik HH; Kim SS; Yoon KS; Ha J; Kang I
    Biochem Biophys Res Commun; 2006 Dec; 351(4):986-92. PubMed ID: 17097050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppression.
    Chandrasekar B; Boylston WH; Venkatachalam K; Webster NJ; Prabhu SD; Valente AJ
    J Biol Chem; 2008 Sep; 283(36):24889-98. PubMed ID: 18632660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin suppresses IkappaB kinase activation induced by tumor necrosis factor-alpha or high glucose in endothelial cells: role of cAMP and AMP kinase signaling.
    Wu X; Mahadev K; Fuchsel L; Ouedraogo R; Xu SQ; Goldstein BJ
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1836-44. PubMed ID: 17940218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of starvation-induced activation of AMP-activated protein kinase in the hypothalamus of the Lou/C rats resistant to obesity.
    Taleux N; De Potter I; Deransart C; Lacraz G; Favier R; Leverve XM; Hue L; Guigas B
    Int J Obes (Lond); 2008 Apr; 32(4):639-47. PubMed ID: 18059408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.
    Funakoshi-Tago M; Kamada N; Shimizu T; Hashiguchi Y; Tago K; Sonoda Y; Kasahara T
    Cytokine; 2009 Feb; 45(2):72-9. PubMed ID: 19091594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthase.
    McCarty MF
    Med Hypotheses; 2004; 63(2):328-33. PubMed ID: 15236798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.